Search

everythinglearnresearchcommunity

for

Search:↓

Two mouse mutations cause similar hair loss despite different skin changes.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Syphilis patients showed abnormal hair root changes, with no difference between primary and secondary stages.

Folliculitis decalvans was successfully treated with doxycycline and ozenoxacin.

Hydroxychloroquine effectively treated twenty-nail dystrophy in a patient with alopecia areata.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Most children with a common hemochromatosis genotype had elevated iron levels but no severe symptoms.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Skin bacteria can help wound healing by activating certain immune cells.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Alopecia patients have higher heart disease risk; statins and finasteride may help.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

TGF-β2 plays a key role in human hair growth and development.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Human prenatal skin develops an immune network early on that helps with skin formation and healing without scarring.

Mexican patients had a lower incidence of skin reactions to drugs and no significant link between these reactions and the TNF2 gene variant.

The skin is vital for protection, temperature control, fluid balance, immunity, and sensing, with damage affecting daily life and mental health.

Lamivudine might reverse hair graying and needs more research for potential treatments.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

Targeting colon cancer stem cells might lead to better treatment results.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.